Login     Register  
    Home  |   Privacy & Security  |   Search  |   About Us  |   Disclaimer  |   Participating on CanBiotech
BioDevicesBiz - Medical Devices and Diagnostics Portal and B2B Marketplace CAR-T therapy is set to revolutionize oncology pipelines and mark a new era for personalized medicine. With the recent approvals of Yescarta and Kymriah and the $11 billion acquisition of Kite, the race is on to lead the commercialization of safe, efficacious and accessible CAR-T therapy.
The fourth annual CAR-T congress USA is bringing together the leading pharmaceutical companies, the disruptive biotechs and pioneering academic institutions to assess emerging novel data and tackle the current challenges including antigen discovery, manufacturing scalability and efficacy.
Site Search:
    Home News Community

If you currently have an account with CanBiotech you can use your username and password to access any of CanBiotech's networks. If you do not have an account, register to access these networks.

Once you register an email will immediately be sent to you to authenticate your registration.
Progress back to the site from that email.

Username
Password
Confirm Password
First Name
Last Name
Email
Job Title
Primary Job Function
Country
  Yes I would like to receive the monthly site newsletter and consent to the site privacy and security policy governing your personal data needed for subscription to the: CanBiotech Newsletter
You can view a sample issue of the CanBiotech Newsletter by clicking the link.
Help

Using the Site Privacy & Security Statement Advertise with us Event Postings CanBiotech Newsletters

© 2000-2019 CanBiotech™ Inc.